Curocell works with experts
Curocell is led by leaders specializing in areas of research, clinic, manufacture and finance. Members of Curocell are exhibiting their capability and potential in cutting-edge medicine development site.
CAR-T technology of Curocell aims to spread throughout the world
Curocell is developing next-generation CAR-T technology that shows curative effacement not only in blood cancer but also in solid cancer. Based on innovative and differentiated technology, we are aiming to expand our domain to global market such as US, Europe and China etc.